BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Celyad Oncology

1 post
Celyad-Oncology-Pauses-CYAD-101-002-Keynote-B79-Phase-1-Trial-After-2-Deaths-Reported

Biotech NewsCelyad Oncology Pauses CYAD-101-002 (Keynote-B79) Phase 1 Trial After 2 Deaths Reported

  • BioTech Health X
  • February 28, 2022
Clinical-stage biotechnology company Celyad Oncology (NASDAQ: CYAD) recently announced that the company has voluntarily paused the CYAD-101-002 (KEYNOTE-B79)…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Accuray (ARAY) Has a $0.28 Price and a $402 Million Revenue Story
  • Nautilus Biotechnology (NAUT) Jumped 24.84% but Sales Tell Another Story
  • Akso Health Group (AHG) Jumps 12.75% but Here’s the Catch
  • Mereo BioPharma Group (MREO) Is Cheap per Share but Is It Cheap Overall?
  • Can HeartBeam (BEAT) Turn Portable Heart Tech Into a Business That Pays?
Featured Posts
    • October 3, 2026
    Accuray (ARAY) Has a $0.28 Price and a $402 Million Revenue Story
    • October 3, 2026
    Nautilus Biotechnology (NAUT) Jumped 24.84% but Sales Tell Another Story
    • October 3, 2026
    Akso Health Group (AHG) Jumps 12.75% but Here’s the Catch
    • October 3, 2026
    Mereo BioPharma Group (MREO) Is Cheap per Share but Is It Cheap Overall?
    • October 3, 2026
    Can HeartBeam (BEAT) Turn Portable Heart Tech Into a Business That Pays?
Recent Posts
  • RedHill Biopharma (RDHL) Hits $0.50 With a Portfolio Plot Twist
    • October 3, 2026
  • PDS Biotechnology (PDSB) Jumped 6% Overnight!
    • October 3, 2026
  • SeaStar Medical (ICU) Surges 25% With a $13.63M Reality Check
    • October 3, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (6)
  • Biotech News (1,100)
  • Uncategorized (2)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top